Revised contraindications for the use of non-medical WB-electromyostimulation. Evidence-based German consensus recommendations
Authors:
Open Access
- 16 April 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Sports and Active Living
- Vol. 6, 1371723
Abstract
Whole-body electromyostimulation has proven to be a highly effective alternative to conventional resistance-type exercise training. However, due to adverse effects in the past, very extensive contraindications have been put in place for the commercial, non-medical WB-EMS market. Considering recent positive innovations e.g., federal regulation, mandatory trainer education, revised guidelines, and new scientific studies on WB-EMS application, we believe that a careful revision of the very restrictive contraindications on WB-EMS is needed. This applies all the more because many cohorts with limited options for conventional exercise have so far been excluded. During a first meeting of an evidence-based consensus process, stakeholders from various backgrounds (e.g., research, education, application) set the priorities for revising the contraindications. We decided to focus on four categories of absolute contraindications: “Arteriosclerosis, arterial circulation disorders”, “Diabetes mellitus” (DM), “Tumor and cancer” (TC), “Neurologic diseases, neuronal disorders, epilepsy”. Based on scientific studies, quality criteria, safety aspects and benefit/risk assessment of the category, DM and TC were moved to the relative contraindication catalogue, while arteriosclerosis/arterial circulation disorders and neurologic diseases/neuronal disorders/epilepsy were still considered as absolute contraindications. While missing evidence suggests maintaining the status of neurologic diseases/neuronal disorders as an absolute contraindication, the risk/benefit-ratio does not support the application of WB-EMS in people with arteriosclerosis/arterial circulation diseases. Despite these very cautious modifications, countries with less restrictive structures for non-medical WB-EMS should consider our approach critically before implementing the present revisions. Considering further the largely increased amount of WB-EMS trials we advice regular updates of the present contraindication list.Keywords
This publication has 37 references indexed in Scilit:
- Visceral fat loss by whole‐body electromyostimulation is attenuated in male and absent in female older Non‐Insulin‐Dependent diabetes patientsEndocrinology, Diabetes & Metabolism, 2022
- Belt Electrode-Skeletal Muscle Electrical Stimulation During Early Hematopoietic Post-Transplantation To Prevent Skeletal Muscle Atrophy and WeaknessTransplantation and Cellular Therapy, 2022
- High protein versus medium protein delivery under equal total energy delivery in critical care: A randomized controlled trialClinical Nutrition, 2021
- Whole-body Electromyostimulation plus Caloric Restriction in Metabolic SyndromeInternational Journal of Sports Medicine, 2020
- Side effects of whole-body electro-myo-stimulationWiener Medizinische Wochenschrift, 2018
- Effects of the belt electrode skeletal muscle electrical stimulation system on lower extremity skeletal muscle activity: Evaluation using positron emission tomographyJournal of Orthopaedic Science, 2016
- Hohe Kreatinkinase-Werte nach exzessiver Ganzkörper-Elektromyostimulation: gesundheitliche Relevanz und Entwicklung im TrainingsverlaufWiener Medizinische Wochenschrift, 2015
- Electrical Myostimulation (EMS) Improves Glucose Metabolism and Oxygen Uptake in Type 2 Diabetes Mellitus Patients—Results from the EMS StudyDiabetes Technology & Therapeutics, 2015
- Electrical myostimulation improves left ventricular function and peak oxygen consumption in patients with chronic heart failure: results from the exEMS study comparing different stimulation strategiesClinical Research in Cardiology, 2013
- Elektromyostimulation (EMS) bei kardiologischen PatientenHerz, 2010